Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Hormel Foods Corp — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Hormel Foods Corp trades at $19.92 (market cap $10.57B). The key difference: Hormel Foods Corp is far larger — about 2.7× Edgewise Therapeutics Inc. Common Stock's market cap, and Hormel Foods Corp pays a 6.09% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Hormel Foods Corp for 99 Days on average.
| EWTX | HRL | |
|---|---|---|
Market Cap | $3.94B | $10.57B |
Volume | 810,104 | 4,381,202 |
Sector | Health | Consumer Staples |
52-Week High | $48.35 | $26.50 |
52-Week Low | $14.89 | $19.19 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $3.48B | $12.56B |
Dividend Yield | — | 6.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Hormel Foods (HRL) trades at $19.81, up 2.64% today, with a mixed technical outlook showing bearish moving averages but oversold RSI signals. The company reported Q2 2026 EPS of $0.37, beating estimates, but net income margin has declined to 2.82% in 2026 from 6.75% in 2024. Recent news highlights the $1.06 billion Brakebush acquisition to expand its chicken business, while the dividend yield remains a key attraction with 60 consecutive years of increases.
The stock offers a compelling dividend history but faces growth challenges with shrinking profit margins and elevated P/E of 30.98. Analyst consensus is cautious with a $25 price target, and the acquisition integration poses execution risk. Upside depends on successful cost management and foodservice expansion, while margin pressure and high payout ratios remain headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
